Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium

European Journal of Cell Biology

Volumn 90, Issue 4, 2011, Pages 323-332

  Shen, Weiyong ^a   Li, Shiying ^a,b   Chung, Sook Hyun ^a   Zhu, Ling ^a   Stayt, Jason ^a   Su, Tao ^a   Couraud, Pierre Olivier ^c   Romero, Ignacio A ^d   Weksler, Babette ^e   Gillies, Mark C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c INSTITUT COCHIN   (France)

^d OPEN UNIVERSITY   (United Kingdom)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Blood brain barrier; Blood retinal barrier; Claudin 5; Transforming growth factor 1; Tyrosine phosphorylation; VE cadherin

Indexed keywords

CARBON 14; CLAUDIN 5; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INULIN; LAVENDUSTIN A; ORTHOVANADIC ACID; POLYCARBONATE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARY PERMEABILITY; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MEMBRANE PROTEINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE; VANADATES;

BOVINAE;

EID: 79951676935     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2010.10.013     Document Type: Article

References (42)

1. Andriopoulou P., Navarro P., Zanetti A., Lampugnani M.G., Dejana E. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2286-2297.
2. Angelini D.J., Hyun S.W., Grigoryev D.N., Garg P., Gong P., Singh I.S., Passaniti A., Hasday J.D., Goldblum S.E. TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L1232-1245.
3. Behzadian M.A., Wang X.L., Windsor L.J., Ghaly N., Caldwell R.B. TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest. Ophthalmol. Vis. Sci. 2001, 42:853-859.
4. Blecharz K.G., Drenckhahn D., Forster C.Y. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J. Cereb. Blood Flow Metab. 2008, 28:1139-1149.
5. Corada M., Mariotti M., Thurston G., Smith K., Kunkel R., Brockhaus M., Lampugnani M.G., Martin-Padura I., Stoppacciaro A., Ruco L., McDonald D.M., Ward P.A., Dejana E. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9815-9820.
6. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 2008, 121:2115-2122.
7. Erickson K.K., Sundstrom J.M., Antonetti D.A. Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis 2007, 10:103-117.
8. Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 1998, 111(Pt 13):1853-1865.
9. Gillies M.C., Sarks J.P., Beaumont P.E., Hunyor A.B., McKay D., Kearns M., McClusky P.J., Sarks S.H. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b. Br. J. Ophthalmol. 1993, 77:759-765.
10. Gillies M.C., Su T. Interferon-alpha 2b enhances barrier function of bovine retinal microvascular endothelium in vitro. Microvasc. Res. 1995, 49:277-288.
11. Gillies M.C., Su T., Naidoo D. Electrical resistance and macromolecular permeability of retinal capillary endothelial cells in vitro. Curr. Eye Res. 1995, 14:435-442.
12. Grinnell K.L., Casserly B., Harrington E.O. Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 298:L361-370.
13. Gu X., Zhang J., Brann D.W., Yu F.S. Brain and retinal vascular endothelial cells with extended life span established by ectopic expression of telomerase. Invest. Ophthalmol. Vis. Sci. 2003, 44:3219-3225.
14. Haorah J., Ramirez S.H., Schall K., Smith D., Pandya R., Persidsky Y. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J. Neurochem. 2007, 101:566-576.
15. Ho J.D., Tsai R.J., Chen S.N., Chen H.C. Removal of sodium from the solvent reduces retinal pigment epithelium toxicity caused by indocyanine green: implications for macular hole surgery. Br. J. Ophthalmol. 2004, 88:556-559.
16. Kaur C., Foulds W.S., Ling E.A. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog. Retin. Eye Res. 2008, 27:622-647.
17. Kim J.H., Park J.A., Lee S.W., Kim W.J., Yu Y.S., Kim K.W. Blood-neural barrier: intercellular communication at glio-vascular interface. J. Biochem. Mol. Biol. 2006, 39:339-345.
18. Kuiper E.J., Hughes J.M., Van Geest R.J., Vogels I.M., Goldschmeding R., Van Noorden C.J., Schlingemann R.O., Klaassen I. Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina. Invest. Ophthalmol. Vis. Sci. 2007, 48:4267-4276.
19. Lee Y.H., Kayyali U.S., Sousa A.M., Rajan T., Lechleider R.J., Day R.M. Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src. Am. J. Respir. Cell Mol. Biol. 2007, 37:485-493.
20. Li J., Wang J.J., Chen D., Mott R., Yu Q., Ma J.X., Zhang S.X. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes. Exp. Eye Res. 2009, 89:71-78.
21. Liebner S., Kniesel U., Kalbacher H., Wolburg H. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur. J. Cell Biol. 2000, 79:707-717.
22. Loizou S., Paraschos S., Mitakou S., Chrousos G.P., Lekakis I., Moutsatsou P. Chios mastic gum extract and isolated phytosterol tirucallol exhibit anti-inflammatory activity in human aortic endothelial cells. Exp. Biol. Med. (Maywood) 2009, 234:553-561.
23. Lu Q., Harrington E.O., Jackson H., Morin N., Shannon C., Rounds S. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation. J. Appl. Physiol. 2006, 101:375-384.
24. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 1990, 6:597-641.
25. May C., Doody J.F., Abdullah R., Balderes P., Xu X., Chen C.P., Zhu Z., Shapiro L., Kussie P., Hicklin D.J., Liao F., Bohlen P. Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 2005, 105:4337-4344.
26. Morcos Y., Hosie M.J., Bauer H.C., Chan-Ling T. Immunolocalization of occludin and claudin-1 to tight junctions in intact CNS vessels of mammalian retina. J. Neurocytol. 2001, 30:107-123.
27. Morita K., Furuse M., Fujimoto K., Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:511-516.
28. Nagy J.A., Benjamin L., Zeng H., Dvorak A.M., Dvorak H.F. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 2008, 11:109-119.
29. Orlova V.V., Economopoulou M., Lupu F., Santoso S., Chavakis T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J. Exp. Med. 2006, 203:2703-2714.
30. Persidsky Y., Heilman D., Haorah J., Zelivyanskaya M., Persidsky R., Weber G.A., Shimokawa H., Kaibuchi K., Ikezu T. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 2006, 107:4770-4780.
31. Potter M.D., Barbero S., Cheresh D.A. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J. Biol. Chem. 2005, 280:31906-31912.
32. Roberts A.B., Flanders K.C., Heine U.I., Jakowlew S., Kondaiah P., Kim S.J., Sporn M.B. Transforming growth factor-beta: multifunctional regulator of differentiation and development. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1990, 327:145-154.
33. Ronaldson P.T., Demarco K.M., Sanchez-Covarrubias L., Solinsky C.M., Davis T.P. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J. Cereb. Blood Flow Metab. 2009, 29:1084-1098.
34. Subileau E.A., Rezaie P., Davies H.A., Colyer F.M., Greenwood J., Male D.K., Romero I.A. Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis. J. Neuropathol. Exp. Neurol. 2009, 68:227-240.
35. Taddei A., Giampietro C., Conti A., Orsenigo F., Breviario F., Pirazzoli V., Potente M., Daly C., Dimmeler S., Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol. 2008, 10:923-934.
36. Tretiach M., Madigan M.C., Wen L., Gillies M.C. Effect of Muller cell co-culture on in vitro permeability of bovine retinal vascular endothelium in normoxic and hypoxic conditions. Neurosci. Lett. 2005, 378:160-165.
37. Tretiach M., van Driel D., Gillies M.C. Transendothelial electrical resistance of bovine retinal capillary endothelial cells is influenced by cell growth patterns: an ultrastructural study. Clin. Experiment. Ophthalmol. 2003, 31:348-353.
38. Turowski P., Martinelli R., Crawford R., Wateridge D., Papageorgiou A.P., Lampugnani M.G., Gamp A.C., Vestweber D., Adamson P., Dejana E., Greenwood J. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J. Cell Sci. 2008, 121:29-37.
39. Versteeg H.H., Nijhuis E., van den Brink G.R., Evertzen M., Pynaert G.N., van Deventer S.J., Coffer P.J., Peppelenbosch M.P. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem. J. 2000, 350(Pt 3):717-722.
40. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005, 19:1872-1874.
41. Yamamoto M., Ramirez S.H., Sato S., Kiyota T., Cerny R.L., Kaibuchi K., Persidsky Y., Ikezu T. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am. J. Pathol. 2008, 172:521-533.
42. Zhang X., Bao S., Lai D., Rapkins R.W., Gillies M.C. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 2008, 57:1026-1033.